Extent of non-compliant medicinal cannabis clinics revealed New research has highlighted the need for more stringent monitoring and regulation when it comes to advertising practices around the prescribing of medicinal cannabis products.
Quetiapine shortage ‘frankly unacceptable’ Some doses of the antipsychotic medication could be in shortage until July, leaving both patients and GPs ‘alarmed’.
‘Too little, too late’: An investigation into medication shortages How are medication shortages affecting GPs and their patients? Calls are being made to change how they are being managed and communicated.
Ozempic shortage extended The manufacturer has informed the TGA that supply will be limited until 31 December 2025, with GPs labelling it an ‘ongoing disappointment’.
‘Deeply concerns me’: Original prescriber’s alarm over cannabis trends Medicinal cannabis prescription rates are skyrocketing, with sales in the first half of 2024 almost equal to all of 2023 – but it comes amid mounting concern.
In Practice: EOIs for 2025 Hackathon event The RACGP’s Hackathon provides the opportunity to be part of developing solutions to general practice challenges, and GPs can apply now.
Embedding Aboriginal and Torres Strait Islander values in GP training A first-of-its-kind training framework aims to ensure clinical education is framed by perspectives of Aboriginal and Torres Strait Islander peoples.
In Practice: Member forum on governance The RACGP is inviting members attending GP24 to join a governance discussion to help shape the future of the college.
Australian-first STI self-test receives TGA approval The test for chlamydia and gonorrhoea could result in timelier diagnosis, but are there implications of doing so outside the healthcare setting?
RACGP pushes for changes to Medicare Safety Net As patients on low incomes continue to forego care due to out-of-pocket costs, the RACGP is urging for safety net thresholds to be lowered.